As indicated above, the proportion of CD161+ Vδ1+ γδ T cells in PBMCs was higher in SSc in particular in IP- patients (1.03% ± 0.30) compared with IP+ SSc patients. This evidence concerns the gene KLRB1 and systemic sclerosis.